| Members |
targetComponentId |
| Candidiasis: [perianal] or [anal] |
Perianal candidiasis |
| Candidiasis: [perianal] or [anal] |
Anal candidiasis |
| Canesten 1% cream 20g |
Product containing precisely clotrimazole 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
| Canesten 1% cream 50g |
Product containing precisely clotrimazole 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
| Canesten 1% solution 20mL |
Clotrimazole 10 mg/mL cutaneous solution |
| Canine brucellosis |
Brucellosis (disorder) |
| Canine species |
Canis lupus subspecies familiaris (organism) |
| Canine species |
Genus Canis (organism) |
| cannabinoid |
Endocannabinoid (substance) |
| cannabinoid |
Cannabinoid receptor agonist |
| Cannabis poisoning |
Poisoning caused by cannabinoid receptor agonist (disorder) |
| Cannabis type drug dependence |
Cannabis dependence |
| afhængighed af stof af cannabistypen |
Cannabis dependence |
| Cannabis/hallucinogen dependency |
Cannabis dependence |
| Cannabis/hallucinogen dependency |
Hallucinogen dependence |
| Cannot pass urine - retention (& [symptom]) |
Retention of urine |
| kanyleprocedure |
Cannula or catheter procedure (procedure) |
| Kanyle, tube OG/ELLER kateter |
Catheter |
| Kanyle, tube OG/ELLER kateter |
Cannula |
| Kanyle, tube OG/ELLER kateter |
Tube |
| Cannulated surgical drill, single-use |
Cannulated surgical drill (physical object) |
| Cannulation of artery |
Arterial cannula insertion (procedure) |
| Cannulation of artery |
Insertion of catheter into artery (procedure) |
| Kanylering af tåreapparatet |
Operation on lacrimal system |
| Kanylering af tåreapparatet |
Intubation of lacrimal drainage structure (procedure) |
| Cape Verde islands |
Cabo Verde (geographic location) |
| Cape Verde islands |
Island in region of Cabo Verde (geographic location) |
| Capercaillie |
Tetrao urogallus (organism) |
| Capercaillie |
Genus Tetrao (organism) |
| Capillaria hepatica |
Capillaria hepatica |
| Capillaria-art |
Capillaria |
| absorberende sårforbinding med hårrørsvirkning 10 cm x 10 cm |
Capillary action wound dressing (physical object) |
| absorberende sårforbinding med hårrørsvirkning 10 cm x 15 cm |
Capillary action wound dressing (physical object) |
| absorberende sårforbinding med hårrørsvirkning 10 cm x 20 cm |
Capillary action wound dressing (physical object) |
| absorberende sårforbinding med hårrørsvirkning 15 cm x 20 cm |
Capillary action wound dressing (physical object) |
| absorberende sårforbinding med hårrørsvirkning 20 cm x 20 cm |
Capillary action wound dressing (physical object) |
| absorberende sårforbinding med hårrørsvirkning 5 cm x 5 cm |
Capillary action wound dressing (physical object) |
| Capnocytophaga-art |
Capnocytophaga |
| Caprine brucellosis |
Infection caused by Brucella melitensis (disorder) |
| Caprine species |
Domestic goat |
| Caprine species |
Genus Capra (organism) |
| Kapsulær og subkapsulær katarakt |
Subcapsular cataract |
| Capsular polysaccharide antigen of Streptococcus pneumoniae serogroup 20 |
Streptococcus pneumoniae serogroup 20 capsular polysaccharide unconjugated antigen |
| Miltkapselbristning uden større parenkymbeskadigelse OG uden åbent sår ind til bughulen |
Capsular tear of spleen |
| Capsulectomy of kidney |
Decortication of kidney (procedure) |
| Capsulectomy of kidney |
Renal capsulectomy |
| Capsulotomy of lens with removal of foreign body |
Surgical removal of foreign body from lens (procedure) |
| Capsulotomy of lens with removal of foreign body |
Capsulotomy of lens with removal of foreign body |
| hovedpræsentation |
Vertex presentation with caput succedaneum (finding) |
| hovedpræsentation |
Caput succedaneum |
| hovedpræsentation |
Vertex presentation |
| Vurdering af bil |
Driving assessment |
| carbamazepin 200 mg tablet med modificeret udløsning |
Product containing precisely carbamazepine 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
| carbamazepin 400 mg tablet med modificeret udløsning |
Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet (clinical drug) |
| Carbamazepine level: [serum] or [blood] |
Serum carbamazepine measurement |
| Carbamazepine level: [serum] or [blood] |
Carbamazepine blood measurement |
| Carbamazepine level: [serum] or [blood] |
Serum carbamazepine measurement |
| Carbamide peroxide otic agent |
Pharmaceutical / biologic product (product) |
| Carbamide peroxide otic agent |
Urea hydrogen peroxide |
| Carbaryl 0.5% alcoholic lotion |
Carbaryl 5 mg/mL cutaneous lotion |
| carbaryl 0,5 % alkoholholdig lotion |
Carbaryl 5 mg/mL cutaneous lotion |
| Carbide dental bur, single-use |
Carbide dental bur |
| bivirkning af co-careldopa |
Adverse reaction to carbidopa and/or levodopa |
| carbocistein 125 mg/5 ml syrup til børn |
Product containing precisely carbocisteine 25 milligram/1 milliliter conventional release oral solution (clinical drug) |
| carbocistein 250 mg/5 ml syrup |
Product containing precisely carbocisteine 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Carbomer-980 2mg/g conventional release eye gel |
Product containing only carbomer-980 in ocular dose form (medicinal product form) |
| carbomer-980 2 mg/g øjengel til engangsbrug |
Product containing only carbomer-980 in ocular dose form (medicinal product form) |
| Carbon dioxide absorber, reusable |
Carbon dioxide absorber |
| Carbon dioxide absorber, single-use |
Carbon dioxide absorber |
| måling af kuldioxid |
Measurement of partial pressure of carbon dioxide in blood |
| måling af kuldioxid |
Carbon dioxide content measurement (procedure) |
| behandling med kuldioxid |
Transdermal administration of carbon dioxide (procedure) |
| behandling med kuldioxid |
Subcutaneous injection of carbon dioxide (procedure) |
| behandling med kuldioxid |
Administration of carbon dioxide via inhalation |
| behandling med kuldioxid |
Cryotherapy of skin lesion with carbon dioxide |
| Carbon tetrachloride |
Carbon tetrachloride |
| carboprost 250 µg/ml injektionsvæske, opløsning, ampul a 1 ml |
Carboprost (as carboprost trometamol) 250 microgram/mL solution for injection |
| Brandbyld |
Furuncle (disorder) |
| Brandbyld |
Carbuncle (disorder) |
| karbunkel/furunkel |
Carbuncle |
| karbunkel/furunkel |
Furuncle |
| karcinoembryonalt antigen påvist |
Carcinoembryonic antigen within reference range |
| karcinoembryonalt antigen påvist |
Carcinoembryonic antigen above reference range (finding) |
| Carcinoembryonic antigen: (& level) |
Carcinoembryonic antigen |
| Carcinoembryonic antigen: (& level) |
Carcinoembryonic antigen |
| Carcinoma cervix uteri: [adenocarcinoma] or [invasive] |
Adenocarcinoma of cervix |
| Carcinoma cervix uteri: [adenocarcinoma] or [invasive] |
Adenocarcinoma of cervix |
| Carcinoma gallbladder |
Primary malignant neoplasm of gallbladder (disorder) |
| Carcinoma gallbladder |
Malignant neoplasm of gallbladder (disorder) |
| Carcinoma gallbladder |
Carcinoma of gallbladder (disorder) |
| Carcinoma in situ of biliary system (& [and liver]) |
Carcinoma in situ of liver and/or biliary system (disorder) |
| Carcinoma in situ of biliary system (& [and liver]) |
Carcinoma in situ of biliary tract |
| Carcinoma in situ of cervix |
Cervical smear - severe dyskaryosis |
| Carcinoma in situ of cervix |
Carcinoma in situ of uterine cervix |
| Carcinoma in situ of cervix |
Cervical intraepithelial neoplasia |
| Carcinoma in situ of digestive sytem: [organs] or [G.I. tract] |
Carcinoma in situ of gastrointestinal tract |
| Carcinoma in situ of digestive sytem: [organs] or [G.I. tract] |
Carcinoma in situ of digestive organ |
| Carcinoma in situ of lacrimal drainage structure |
Carcinoma in situ of lacrimal gland duct (disorder) |
| Carcinoma in situ of lacrimal drainage structure |
Carcinoma in situ of lacrimal drainage system (disorder) |
| Carcinoma in situ i tårekanal |
Carcinoma in situ of lacrimal gland duct (disorder) |
| Carcinoma in situ i tårekanal |
Carcinoma in situ of nasolacrimal duct (disorder) |
FHIR